SQA
SLS icon

Simon Quick Advisors’s SELLAS Life Sciences SLS Stock Holding History

Simon Quick Advisors’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$295K Hold
20,000
– – 0.01% 336
2026
Q1 		$84.6K Hold
20,000
– – ﹤0.01% 374
2025
Q4 		$75.4K Hold
20,000
– – ﹤0.01% 386
2025
Q3 		$32.2K Hold
20,000
– – ﹤0.01% 395
2025
Q2 		$43.8K Buy
+20,000
New +$30.7K ﹤0.01% 356

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Simon Quick Advisors's SLS Position: Q2 2026 in Review

Simon Quick Advisors held its SELLAS Life Sciences (SLS) position steady in Q2 2026 at 20,000 shares worth $295K. The position accounts for 0.01% of the portfolio, ranked #336.

Simon Quick Advisors first reported a position in SLS in Q2 2025 and has held it in 5 quarters since. 192 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Simon Quick Advisors held 20,000 shares of SELLAS Life Sciences worth $295K as of Q2 2026.
  • Simon Quick Advisors left its SELLAS Life Sciences share count unchanged in Q2 2026.
  • SELLAS Life Sciences made up 0.01% of Simon Quick Advisors's portfolio in Q2 2026, its #336 holding.
  • Simon Quick Advisors first reported a position in SELLAS Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • 192 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Simon Quick Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.